2. Albertazzi P, Bottazzi M, Steel SA. Bone mineral density and depot medroxyprogesterone acetate. Contraception. 2006;73:577-83. Abstract: INTRODUCTION: Depot medroxyprogesterone acetate (DMPA) suppresses pituitary gonadotrophin output, thus, suppressing ovulation. Estrogen production from the ovary is also strongly inhibited, and the resulting estrogen deficiency has a detrimental impact on b...

BACKGROUND The evidence from epidemiological research into whether use of hormonal contraception increases women's risk of HIV acquisition is inconsistent. We did a robust meta-analysis of existing data to provide summary estimates by hormonal contraceptive method which can be used to inform contraceptive guidelines, models, and future studies. METHODS We updated a recent systematic review to...

This paper describes experiments designed to test the effect of depot medroxyprogesterone acetate (DMPA) on calcium metabolism of adult ovariectomized rats. The 24 animals were randomly assigned to control or treated groups. Treated rats received 15 mg of DMPA i.m. per week, during four or twelve weeks. Controls received solvent alone. The variables characterizing the metabolism of Ca (daily ra...

The Contraceptive Equality Mandate took effect in Wisconsin on January 1, 2010. This mandate from the Wisconsin Office of the Commissioner of Insurance requires all insurance companies in the state of Wisconsin to cover all types of contraception, making Wisconsin the 28th state to do so. This article reviews the literature related to several types of contraception including Implanon (a newly a...